Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, leading to pain and potentially severe disability. The exact cause of AS remains unclear, but it is known to involve a combination of genetic and environmental factors. Recent research has begun to explore the potential role of vitamin D in the pathogenesis and management of ankylosing spondylitis, sparking interest in its implications for patients and healthcare providers.
Understanding Ankylosing Spondylitis
AS is categorized under spondyloarthritis, a group of inflammatory rheumatic diseases that cause arthritis. It predominantly affects young adults, with symptoms typically beginning in late adolescence or early adulthood. The hallmark feature of AS is inflammation of the axial skeleton, which can lead to the fusion of vertebrae, causing a loss of flexibility and mobility. The disease's progression varies widely among individuals, with some experiencing only mild symptoms while others suffer from significant pain and disability.
The pathophysiology of AS involves an inappropriate immune response, where the body's immune system mistakenly attacks its own tis...
Premium preview
Premium members unlock the full article—complete step-by-step routines, deeper coaching notes, and exclusive frameworks.